Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Research in the area of immunization reported from Medical University of Vienna
June 24th, 2009
New investigation results, 'T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans,' are detailed in a study published in Clinical & Experimental Allergy. "Allergen-specific T helper 2 (Th2) cells play an important role in the pathogenesis of atopic disorders. To date, no model system exists in humans that would allow the monitoring of a developing de novo Th2 immune response in vivo," scientists writing in the journal Clinical & Experimental Allergy report. "The aim of the experiment was to establish an immunization protocol inducing a de novo Th2 response in humans using Keyhole Limpet Hemocyanin (KLH) as neo-antigen. The...
Source: Vaccine Weekly (2009-06-24)
|
